Literature DB >> 12193438

Treatment with cyclosporin A in a patient with Omenn's syndrome.

A Meyer-Bahlburg1, J-P Haas, R Haase, U Eschrich, A Wawer, L Frank, W Ch Marsch, S Burdach, G Horneff.   

Abstract

Unless treated with haematopoetic stem cell transplantation, Omenn's syndrome, a rare variant of severe combined immunodeficiency, is associated with a fatal outcome. We describe a male infant showing all the typical features of Omenn's syndrome, who was successfully treated with cyclosporin A to improve clinical condition prior to haematopoetic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193438      PMCID: PMC1719228          DOI: 10.1136/adc.87.3.231

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  2 in total

1.  Acquired Omenn-like syndrome, a novel posttransplant autoaggression syndrome reversed by rapamycin.

Authors:  Donald C Vinh; Khalid Bin Dhuban; Helen Mason; Duncan Lejtenyi; Sungmi Jung; Donald C Sheppard; Damien Faury; Nada Jabado; Ciriaco A Piccirillo
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

2.  Selective clinical and immune response of the oligoclonal autoreactive T cells in Omenn patients after cyclosporin A treatment.

Authors:  A Lev; A J Simon; N Amariglio; G Rechavi; R Somech
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.